CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Seventh Annual JMP Securities Healthcare Conference on Thursday, July 12, 2012 at 11:00 a.m. ET at the Peninsula New York.
